Skip to main content

FDA Panel Approves New Liver Drug

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments.

Republish
Lead image for this article

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments. The liver disease, primary biliary cirrhosis, destroys bile ducts in the liver and can lead to patients requiring liver transplants. (The Wall Street Journal)

Texans need truth. Help us report it.

Our Fall Member Drive is underway, and we need your support. The Texas Tribune is a critical source of truth and information for Texans across the state and beyond — and our community of members, the readers who donate, make our work possible. Will you join as a member with a tax-deductible donation of any amount?

Yes, I'll donate today

Information about the authors

Jacob Sanchez’s staff photo

Explore related story topics